93 related articles for article (PubMed ID: 25263389)
21. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
23. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
[TBL] [Abstract][Full Text] [Related]
24. [Abnormal Expression of p120-catenin and E-cadherin Is Significantly Correlated with Malignant Phenotype of Human Lung Cancer.].
Wang M; Liu Y; Liu S; Wang E
Zhongguo Fei Ai Za Zhi; 2009 Apr; 12(4):306-11. PubMed ID: 20719116
[TBL] [Abstract][Full Text] [Related]
25. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I
Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation.
Kim CH; Nam HS; Lee EH; Han SH; Cho HJ; Chung HJ; Lee NS; Choi SJ; Kim H; Ryu JS; Kwon J; Kim H
Cell Cycle; 2013 Aug; 12(15):2443-53. PubMed ID: 23839039
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
29. Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer.
Chen CC; Chen HY; Su KY; Hong QS; Yan BS; Chen CH; Pan SH; Chang YL; Wang CJ; Hung PF; Yuan S; Chang GC; Chen JJ; Yang PC; Yang YC; Yu SL
Am J Respir Crit Care Med; 2014 Aug; 190(4):433-44. PubMed ID: 25036006
[TBL] [Abstract][Full Text] [Related]
30. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
32. [Expression of p120ctn and its significance in non-small cell lung cancer].
Xie CY; Wang L; Liu Y; Liu N; Qiu XS; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):206-10. PubMed ID: 16091173
[TBL] [Abstract][Full Text] [Related]
33. Diversin increases the proliferation and invasion ability of non-small-cell lung cancer cells via JNK pathway.
Luan L; Zhao Y; Xu Z; Jiang G; Zhang X; Fan C; Liu D; Zhao H; Xu K; Wang M; Yu X; Wang E
Cancer Lett; 2014 Mar; 344(2):232-8. PubMed ID: 24246849
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
35. A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis.
Chen CH; Chuang SM; Yang MF; Liao JW; Yu SL; Chen JJ
Mol Cancer Res; 2012 Oct; 10(10):1319-31. PubMed ID: 22912335
[TBL] [Abstract][Full Text] [Related]
36. Kaiso is expressed in lung cancer: its expression and localization is affected by p120ctn.
Dai SD; Wang Y; Jiang GY; Zhang PX; Dong XJ; Wei Q; Xu HT; Li QC; Zhao C; Wang EH
Lung Cancer; 2010 Feb; 67(2):205-15. PubMed ID: 19615783
[TBL] [Abstract][Full Text] [Related]
37. SCUBE3 overexpression predicts poor prognosis in non-small cell lung cancer.
Zhao C; qin Q; Wang Q; Zhang J; Xu Y; Li W; Gu M; Chen S; Deng A
Biosci Trends; 2013 Dec; 7(6):264-9. PubMed ID: 24390364
[TBL] [Abstract][Full Text] [Related]
38. Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.
Fang C; Jiang B; Shi X; Fan C
Int J Med Sci; 2019; 16(3):470-476. PubMed ID: 30911281
[No Abstract] [Full Text] [Related]
39. DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling.
Yang Y; Liu L; Cai J; Wu J; Guan H; Zhu X; Yuan J; Li M
Biochem Biophys Res Commun; 2014 Jul; 450(1):899-905. PubMed ID: 24971537
[TBL] [Abstract][Full Text] [Related]
40. PYGB facilitates cell proliferation and invasiveness in non-small cell lung cancer by activating the Wnt-β-catenin signaling pathway.
Xiao L; Wang W; Huangfu Q; Tao H; Zhang J
Biochem Cell Biol; 2020 Oct; 98(5):565-574. PubMed ID: 32191839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
